Patient Capital Management’s Illumina ILMN Stock Holding History

Patient Capital Management’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.1M	Sell	544,780 -30,988	-5%	-$4.07M	2.46%	20
2025 Q4	$75.5M	Sell	575,768 -5,591	-1%	-$656K	2.91%	15
2025 Q3	$55.2M	Sell	581,359 -831	-0.1%	-$82.4K	2.21%	23
2025 Q2	$55.5M	Buy	582,190 +123,521	+27%	+$10M	2.51%	21
2025 Q1	$36.4M	Buy	458,669 +48,714	+12%	+$5.27M	1.87%	26
2024 Q4	$54.8M	Sell	409,955 -1,600	-0.4%	-$228K	2.53%	23
2024 Q3	$53.7M	Sell	411,555 -3,303	-0.8%	-$407K	2.64%	19
2024 Q2	$43.3M	Buy	414,858 +162,703	+65%	+$18.3M	2.3%	22
2024 Q1	$33.7M	Buy	252,155 +4,738	+2%	+$635K	1.64%	30
2023 Q4	$33.5M	Buy	+247,417	New	+$28.5M	1.78%	29

Other funds holding ILMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Patient Capital Management's ILMN Position: Q1 2026 in Review

Patient Capital Management reduced its Illumina (ILMN) stake by 5.4% in Q1 2026, selling an estimated $4.07M and leaving 544,780 shares worth $67.1M. The position accounts for 2.46% of the portfolio, ranked #20.

Patient Capital Management first reported a position in ILMN in Q4 2023 and has held it in 10 quarters since. The position peaked at $75.5M in Q4 2025. 846 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

Patient Capital Management held 544,780 shares of Illumina worth $67.1M as of Q1 2026.
Patient Capital Management sold 30,988 Illumina shares in Q1 2026, an estimated $4.07M.
Illumina made up 2.46% of Patient Capital Management's portfolio in Q1 2026, its #20 holding.
Patient Capital Management first reported a position in Illumina in Q4 2023 and has held it in 10 quarters since.
Patient Capital Management's Illumina position peaked at $75.5M in Q4 2025.
846 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.